Moderna
MRNA
#290
Rank
ยฃ60.25 B
Marketcap
ยฃ148.91
Share price
-2.17%
Change (1 day)
704.40%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Net assets

Net assets on the balance sheet as of June 2026 : ยฃ5.16 Billion

According to Moderna 's latest financial reports the company has ยฃ5.16 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Moderna - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ6.42 B-26.06%
2024-12-31$ยฃ8.68 B-20.12%
2023-12-31$ยฃ10.87 B-31.2%
2022-12-31$ยฃ15.80 B50.84%
2021-12-31$ยฃ10.47 B457.74%
2020-12-31$ยฃ1.87 B109.71%
2019-12-31$ยฃ0.89 B-25.68%
2018-12-31$ยฃ1.20 B160.56%
2017-12-31$ยฃ0.46 B-32.19%
2016-12-31$ยฃ0.68 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
ยฃ62.25 B 1,105.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ28.68 B 455.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ32.06 B 520.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ52.71 M-98.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ27.8 Million-100.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.75 B-46.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ0.35 B-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA